title: Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis.
abstract: Colorectal cancer (CRC) is a major public health concern, ranking among the leading causes of cancer death in both men and women. Because of this continued burden there is a clear need for improved treatment, and more importantly prevention of this disease. In recent years there is significant evidence to support the hypothesis that guanylyl cyclase C (GCY2C) is a tumor suppressor in the intestine, and that the loss of hormone ligands for this receptor is an important step in the disease process. Thus, ligand replacement therapy has been proposed as a strategy to prevent CRC. Until recently this strategy was not clinically plausible; however, the recent regulatory approval of linaclotide (LINZESS™, Forest Laboratories and Ironwood Pharmaceuticals, Inc.), an oral GUCY2C ligand, has raised the possibility of utilizing this strategy clinically to prevent CRC.
authors: Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, 132 S. 10th St. 1170 Main Philadelphia, Pennsylvania 19107, USA.
authors: Erik S
authors: ES
authors: Blomain
authors: Jieru E
authors: JE
authors: Lin
authors: Crystal L
authors: CL
authors: Kraft
authors: Urszula T
authors: UT
authors: Trela
authors: Justin M
authors: JM
authors: Rock
authors: Amanda S
authors: AS
authors: Aing
authors: Adam E
authors: AE
authors: Snook
authors: Scott A
authors: SA
authors: Waldman
mesh_terms: D000818:Animals; D016588:Anticarcinogenic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000201:enzymology / Q000517:prevention & control*; D055808:Drug Discovery; D006801:Humans; D008024:Ligands; D010455:Peptides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled / Q000819:agonists*; D018000:Receptors, Peptide / Q000819:agonists*
chemical_list: D016588:Anticarcinogenic Agents; D008024:Ligands; D010455:Peptides; D018000:Receptors, Peptide; C000613654:GUCY2C protein, human; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; C523483:linaclotide
references: Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3046-50
references: 7708772
references: Nat Rev Clin Oncol. 2011 Mar;8(3):184-7
references: 21364692
references: Expert Opin Investig Drugs. 2009 Dec;18(12):1829-42
references: 19938898
references: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references: 22237781
references: Curr Opin Mol Ther. 2007 Aug;9(4):403-10
references: 17694454
references: Gastroenterology. 2010 Dec;139(6):1877-1886.e2
references: 20801122
references: Cancer Res. 1990 Dec 1;50(23):7717-22
references: 2253215
references: CA Cancer J Clin. 2013 Jan;63(1):11-30
references: 23335087
references: Clin Cancer Res. 2006 Aug 1;12(15):4545-52
references: 16899600
references: Proc Natl Acad Sci U S A. 1978 Jun;75(6):2800-4
references: 26915
references: Cancer Res. 2001 Apr 1;61(7):3124-30
references: 11306497
references: Clin Pharmacol Ther. 2007 Oct;82(4):441-7
references: 17687268
references: N Engl J Med. 2012 Feb 23;366(8):707-14
references: 22356324
references: Cancer Res. 2003 Aug 15;63(16):4878-81
references: 12941809
references: World J Gastroenterol. 2013 Feb 21;19(7):984-93
references: 23467658
references: Hum Pathol. 2005 Feb;36(2):170-9
references: 15754294
references: Pharmacol Rev. 2000 Sep;52(3):375-414
references: 10977868
references: Science. 1995 Jun 2;268(5215):1336-8
references: 7761852
references: Cancer Prev Res (Phila). 2011 Mar;4(3):311-23
references: 21372031
references: Dis Colon Rectum. 2006 Jan;49(1):113-24; discussion 124-5
references: 16362805
references: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2695-9
references: 12594332
references: Am J Gastroenterol. 2009 Oct;104(10):2626-7; author reply 2628-9
references: 19806090
references: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5522-7
references: 10318916
references: J Infect Dis. 1980 Aug;142(2):220-8
references: 6106030
references: J Natl Cancer Inst. 2011 Jan 19;103(2):117-28
references: 21228314
references: Gastroenterology. 2007 Aug;133(2):599-607
references: 17681179
references: Bioorg Med Chem Lett. 2009 Sep 15;19(18):5297-301
references: 19683923
references: Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):473-84
references: 22122764
references: Genomics. 1996 Jun 1;34(2):265-7
references: 8661067
references: Cancer Res. 2000 Sep 15;60(18):5151-7
references: 11016642
references: Am J Hum Genet. 1994 Oct;55(4):659-65
references: 7942843
references: Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7846-51
references: 11438734
references: Gastroenterology. 2010 Jan;138(1):241-54
references: 19737566
references: Cancer Res. 2002 Aug 1;62(15):4352-63
references: 12154040
references: Cancer Res. 2009 Apr 15;69(8):3529-36
references: 19336567
references: Drug News Perspect. 2009 Jul-Aug;22(6):313-8
references: 19771320
references: Genome Res. 2012 Feb;22(2):188-95
references: 22301133
references: Cell. 1990 Nov 30;63(5):941-8
references: 1701694
references: Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):301-10
references: 21651347
references: Am J Gastroenterol. 2012 Nov;107(11):1714-24; quiz p.1725
references: 22986440
references: Am J Pathol. 2002 Dec;161(6):2169-78
references: 12466132
references: J Natl Cancer Inst. 2002 Feb 20;94(4):252-66
references: 11854387
references: Am J Gastroenterol. 2012 Nov;107(11):1702-12
references: 22986437
references: Science. 2004 Apr 23;304(5670):554
references: 15016963
references: PLoS One. 2012;7(2):e31686
references: 22384056
references: PLoS One. 2011 Jan 31;6(1):e16139
references: 21305056
references: Oncogene. 2004 Aug 23;23(38):6365-78
references: 15322511
references: Annu Rev Pathol. 2011;6:479-507
references: 21090969
references: Am J Pathol. 2007 Dec;171(6):1847-58
references: 17974601
references: Am J Surg. 1984 Apr;147(4):477-80
references: 6711749
references: Am J Epidemiol. 2011 Nov 15;174(10):1127-39
references: 21984660
references: J Gastrointest Cancer. 2013 Mar;44(1):1-11
references: 22878898
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: Cochrane Database Syst Rev. 2000;(2):CD001216
references: 10796760
references: J Cancer. 2013;4(3):217-26
references: 23459594
references: Gastroenterology. 2010 Jun;138(6):2101-2114.e5
references: 20420949
references: Oncogene. 1999 Dec 20;18(55):7860-72
references: 10630639
references: Clin Pharmacol Ther. 2010 Mar;87(3):356-61
references: 20130565
references: Adv Ther. 2013 Mar;30(3):203-11
references: 23436110
references: Gut. 2008 Sep;57(9):1246-51
references: 18337322
references: Cell. 2000 Jan 7;100(1):57-70
references: 10647931
references: Am J Gastroenterol. 2011 Jul;106(7):1340-50
references: 21407185
references: Curr Med Res Opin. 2013 Feb;29(2):149-60
references: 23198977
references: Gastroenterology. 2007 Sep;133(3):761-8
references: 17854590
references: Life Sci. 2010 May 8;86(19-20):760-5
references: 20307554
references: Aliment Pharmacol Ther. 2013 Jan;37(1):49-61
references: 23116208
references: Lab Invest. 1998 Jan;78(1):101-8
references: 9461126
references: Mayo Clin Proc. 2002 Sep;77(9):951-6
references: 12233928
references: N Engl J Med. 2003 Apr 24;348(17):1625-38
references: 12711737
references: Clin Colon Rectal Surg. 2009 Nov;22(4):191-7
references: 21037809
references: Ann Intern Med. 2004 Sep 7;141(5):401-3
references: 15353432
references: Ann Intern Med. 2004 Sep 7;141(5):352-9
references: 15353426
references: Infect Immun. 1993 Nov;61(11):4710-5
references: 8104900
references: Nat Rev Clin Oncol. 2010 Mar;7(3):153-62
references: 20142816
references: Am J Med Sci. 2009 Aug;338(2):96-106
references: 19680014
references: Genet Med. 2009 Aug;11(8):559-67
references: 19617843